Inventor
NEYTS JOHAN
BE40 patents
⚠️ This page may combine multiple inventors who share the name “NEYTS JOHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LEUVEN KATH
11 patentsUS10550123B2Feb 4, 2020
Viral replication inhibitors
UNIV LEUVEN KATH3 citations69
US11566025B2Jan 31, 2023
Viral replication inhibitors
UNIV LEUVEN KATH0 citations59
US12012411B2Jun 18, 2024
Viral replication inhibitors
UNIV LEUVEN KATH0 citations58
US11279704B2Mar 22, 2022
Viral replication inhibitors
UNIV LEUVEN KATH0 citations58
US12070494B2Aug 27, 2024
Chimeric flavivirus lyssavirus vaccines
UNIV LEUVEN KATH0 citations56
US11680084B2Jun 20, 2023
Live-attenuated flaviruses with heterologous antigens
UNIV LEUVEN KATH0 citations55
US11351240B2Jun 7, 2022
Chimeric yellow fever ZIKA virus strain
UNIV LEUVEN KATH0 citations50
US10076564B2Sep 18, 2018
Bacterial artificial chromosomes
UNIV LEUVEN KATH0 citations50
US10633378B2Apr 28, 2020
Viral replication inhibitors
UNIV LEUVEN KATH0 citations48
US12558410B2Feb 24, 2026
Lassavirus vaccines
UNIV LEUVEN KATH0 citations42
US12545709B2Feb 10, 2026
Chimeric filovirus vaccines
UNIV LEUVEN KATH0 citations42
KOREA RES INST CHEMICAL TECH
4 patentsUS9951058B2Apr 24, 2018
Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
KOREA RES INST CHEMICAL TECH2 citations70
US9890133B2Feb 13, 2018
Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
KOREA RES INST CHEMICAL TECH2 citations70
US9790197B2Oct 17, 2017
Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
KOREA RES INST CHEMICAL TECH2 citations70
US9833423B2Dec 5, 2017
1,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
KOREA RES INST CHEMICAL TECH2 citations68
NEYTS JOHAN
3 patentsJUNG YOUNG SIK
2 patentsUS9464067B2Oct 11, 2016
Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
JUNG YOUNG SIK3 citations68
US9346749B2May 24, 2016
1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
JUNG YOUNG SIK2 citations57
UNIV MARYLAND
2 patentsUS10226434B2Mar 12, 2019
Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
UNIV MARYLAND3 citations65
US10058516B2Aug 28, 2018
Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
UNIV MARYLAND2 citations65